Surprisingly, AID expression was found to be higher in IgV-UM CLL cases and to correlate with a shorter treatment free and overall survival, irrespective of IgV mutation status, and with adverse risk cytogenetic aberrations [11],[12]. The gene discussed is AICDA; the disease is B-cell chronic lymphocytic leukemia.